Table 2 Clinical and biological characteristics according to CAD severity
Characteristics | Total (n = 731) | Single-vessel CAD (n = 260) | Multi-vessel CAD (n = 471) | P-value |
|---|---|---|---|---|
Age (years) | 63 (58, 68) | 63 (57, 68) | 63 (58, 69) | 0.361 |
Sex (M/F) | 1.42 | 1.10 | 1.65 | 0.009 |
SBP (mmHg) | 140 (127, 156) | 140 (126, 154) | 141 (127, 156) | 0.225 |
DBP (mmHg) | 83 (76, 91) | 83 (76, 90) | 83 (76, 91) | 0.944 |
BMI (kg/m2) | 26.67 ± 3.90 | 26.47 ± 3.75 | 26.86 ± 3.91 | 0.077 |
Drinking | 253 (34.6%) | 91 (35.0%) | 162 (34.4%) | 0.506 |
Smoking | 363 (49.7%) | 123 (47.3%) | 240 (51.0%) | 0.084 |
TC (mg/dL) | 4.61 (3.87, 5.43) | 4.45 (3.78, 5.21) | 4.69 (3.92, 5.63) | 0.018 |
TG (mg/dL) | 1.51 (1.11, 2.17) | 1.42 (1.05, 2.04) | 1.57 (1.14, 2.21) | 0.018 |
HDL-C (mg/dL) | 1.05 (0.88, 1.24) | 1.10 (0.92, 1.32) | 1.03 (0.87, 1.21) | 0.002 |
LDL-C (mg/dL) | 2.72 (2.14, 3.39) | 2.63 (2.02, 3.20) | 2.80 (2.19, 3.50) | 0.002 |
FPG (mmol/L) | 6.44 (5.53, 8.66) | 5.98 (5.28, 7.34) | 6.71 (5.66, 9.40) |  < 0.001 |
HbA1c (%) | 6.1 (5.6, 7.0) | 6.0 (5.5, 6.5) | 6.2 (5.7, 7.3) |  < 0.001 |
TyG index | 7.42 (7.04, 7.94) | 7.32 (6.93, 7.75) | 7.52 (7.10, 8.06) |  < 0.001 |
Glucose metabolism state | ||||
 NGR | 93 (12.7%) | 45 (17.3%) | 48 (10.2%) |  < 0.001 |
 Pre-DM | 265 (36.3%) | 113 (43.5%) | 152 (32.3%) | |
 DM | 373 (51.0%) | 102 (39.2%) | 271 (57.5%) | |
Drug therapy | ||||
 Antihypertensive | 545 (74.6%) | 196 (75.4%) | 349 (74.1%) | 0.461 |
 Antilipidemic | 561 (76.7%) | 198 (76.2%) | 363 (77.1%) | 0.518 |
 Antiplatelet | 708 (96.9%) | 246 (94.6%) | 462 (98.1%) | 0.010 |